Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I-βCIT and 123I-IBZM SPECT study

Movement Disorders

Volumn 19, Issue 11, 2004, Pages 1320-1325

  Boesch, Sylvia M ^a   Donnemiller, Eveline ^a   Müller, Jörg ^a   Seppi, Klaus ^a   Weirich Schwaiger, Helga ^a   Poewe, Werner ^a   Wenning, Gregor K ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

ADCA; Dopamine; SCA2; SPECT

Indexed keywords

BENZAMIDE DERIVATIVE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; IODINE 123; TROPANE DERIVATIVE;

ADULT; ARTICLE; BASAL GANGLION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LIMB MOVEMENT; MALE; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NEUROTRANSMISSION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINOCEREBELLAR DEGENERATION; TREMOR;

ADULT; BASAL GANGLIA; BENZAMIDES; CEREBELLUM; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DYSTONIC DISORDERS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PYRROLIDINES; RECEPTORS, DOPAMINE D2; REFERENCE VALUES; SPINOCEREBELLAR ATAXIAS; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 8844241499     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20159     Document Type: Article

References (38)

1. Imbert G, Saudou F, Yvert G, et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 1996;14:285-291.
2. Sanpei K, Takano H, Igarashi S, et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 1996;14: 277-284.
3. Pulst SM, Nechiporuk A, Nechiporuk T, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 1996;14:269-276.
4. Geschwind DH, Perlman S, Figueroa CP, Treiman U, Pulst SM. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet 1997; 60:842-850.
5. Gwinn-Hardy K, Chen JY, Liu HC, et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 2000;55: 800-805.
6. Cancel G, Durr A, Didierjean O, et al;. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet 1997;6:709-715.
7. Durr A, Smadja D, Cancel G, et al. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 1995;118(Pt 6):1573-1581.
8. Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G. Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol (Berl) 1999;97:306-310.
9. Shan DE, Soong BW, Sun CM, Lee SJ, Liao KK, Liu RS. Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism. Ann Neurol 2001;50:812-815.
10. Furtado S, Farrer M, Tsuboi Y, et al. SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings. Neurology 2002;59:1625-1627.
11. Lopes-Cendes IE, Andermann E, Attig F, et al. Confirmation of the SCA-2 locus as an alternative locus for dominantly inherited spinocerebellar ataxias and refinement of the candidate region. Am J Hum Genet 1994;54:774-781.
12. 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease. Mov Disord 1998;13:438-445.
13. Pan TS, King MA, Luo DS, Dahlberg ST, Villegas BJ. Estimation of attenuation maps from scatter and photopeak window single photon-emission computed tomographic images of technetium, 99m-labeled sestamibi. J Nucl Cardiol 1997;4(Pt 1): 42-51.
14. Schols L, Peters S, Szymanski S, et al. Extrapyramidal motor signs in degenerative ataxias. Arch Neurol 2000;57:1495-1500.
15. Hallett M, Berardelli A, Matheson J, Rothwell J, Marsden CD. Physiological analysis of simple rapid movements in patients with cerebellar deficits. J Neurol Neurosurg Psychiatry 1991;54:124-133.
16. Diener HC, Dichgans J. Pathophysiology of cerebellar ataxia [review]. Mov Disord 1992;7:95-109.
17. Deuschl G, Heinen F, Kleedorfer B, Wagner M, Lucking CH, Poewe W. Clinical and polymyographic investigation of spasmodic torticollis. J Neurol 1992;239:9-15.
18. Giunti P, Sabbadini G, Sweeney MG, et al. The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain 1998;121(Pt 3):459-467.
19. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117 (Pt 4):835-845.
20. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147.
21. Tison F, Yekhlef F, Chrysostome V, et al. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III),and disability assessment compared with Parkinson's disease. Mov Disord 2002;17:701-709.
22. Boesch SM, Wenning GK, Ransmayr G, Poewe W. Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002;72: 300-303.
23. Wenning GK, Ebersbach G, Verny M, et al. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord 1999; 14:947-950.
24. Marek K, Innis R, van Dyck C, et al. [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology 2001;57:2089-2094.
25. Pirker W, Asenbaum S, Bencsits G, et al. 123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord 2000;15:1158-1167.
26. Pirker W, Asenbaum S, Hank M, et al. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med 2000;41:36-44.
27. Marek K, Seibyl J, Shoulson I, et al. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 2002;287:1653-1661.
28. Yen TC, Tzen KY, Chen MC, et al. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers. J Nucl Med 2002;43:153-159.
29. Yen TC, Lu CS, Tzen KY, et al. Decreased dopamine transporter binding in Machado-Joseph disease. J Nucl Med 2000;41:994-998.
30. Lu CS, Wu Chou YH, Yen TC, Tsai CH, Chen RS, Chang HC. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2. Mov Disord 2002;17:1046-1051.
31. Pirker W, Back C, Gerschlager W, Laccone F, Alesch F. Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2. Mov Disord 2003;18:222-225.
32. Schulz JB, Klockgether T, Petersen D, et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994;57:1047-1056.
33. van Royen E, Verhoeff NF, Speelman JD, Wolters EC, Kuiper MA, Janssen AG. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol 1993;50:513-516.
34. Kim YJ, Ichise M, Ballinger JR, et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 2002;17:303-312.
35. Brucke T, Podreka I, Angelberger P, et al. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders. J Cereb Blood Flow Metab 1991;11:220-228.
36. Hierholzer J, Cordes M, Schelosky L, et al. Dopamine D2 receptor imaging with iodine-123-iodobenzamine in idiopathic rotational torticollis. J Nucl Med 1994;35:1921-1927.
37. Naumann M, Pirker W, Reiners K, Lange KW, Becker G, Brucke T. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using epidepride and 123 beta-CIT. Mov Disord 1998;13:319-323.
38. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The patho-physiology of primary dystonia [review]. Brain 1998;121(Pt 7):1195-1212.